list of participants/lecturers - springer978-94-010-0892-1/1.pdflist of participants/lecturers or....
TRANSCRIPT
LIST OF PARTICIPANTS/LECTURERS
Or. Judit Balazs ~niversity of Medicine pepartment of Psychiatry and Psychotherapy aalassa u. 6. Budapest H-1083 HUNGARY
Or. Silvia Borissova iUniversity Hospital !section of Social Psychiatry
11 "St. Georgii Sofiiski" Street ,BULGARIA
Dr. Pat Brennan Emory University Department of Psychology Altanta, GA 30322 USA
Dr:-Sertalan Csillik Bay Zoltan Foundation for Applied Research Institute for Biotechnology Derkovits fasor 2 H-6726 HUNGARY
Dr. Frantisek Faltus Charles University Department of Psychiatry Ke Karlovu 11 Ke Karlovu 11 128 08 Praha 2 CZECH REPUBLIC
Dr. Antonio Castro Fonseca Universidade de Coimbra Faculdade de Psicologia e de Ciencias da Educacao 3000 Coimbra PORTUGAL
Dr. Kimon Ganev University Psychiatric Clinic Section of Social Psychiatry 1 G. Sofiiski Street 1431 Sofia BULGARIA
253
Dr. Istvan Bitter Institute for Postgraduate Education Department of Psychiatry and Psychotherapy Blassa u.6. Budapest H-1083 HUNGARY
Dr. John Brekke University of Southern California School of Social Work University Park Los Angeles, CA 90089-0411 USA
Dr. Barbara Cornblatt Hillside Hospital Psychiatry R~search 75-59 263'" Street Glen Oaks, NY 11004 USA
Dr. Vitaliy Egorov Crimean Psychiatric Hospital #1 Department of Forensic Psychiatry R. Luxemburg str. 27 Simferopol 333006 Crimea UKRAINE
Dr. Maria Luiza Flonta University of Bucharest Department of Biology Splaiullndependentei 91-95 76201 Bucharest ROMANIA
Dr. Svein Friis Ulleval University Hospital Department of Research and Education Division of Psychiatry N-0407 Oslo NORWAY
Dr. Damianka Getova Medical University Department of Pharmacology Evlogy Georgiev str. 155 1504 Sofia BULGARIA
254
Dr. Ian Falloon Via Case Sparse 10 28040 Lesa Novara ITALY
Dr. Matti Huttunen Kolmas Linja 20 821 00530 Helsinki 53 FINLAND
Dr. Peter Jones University of Nottingham Division of Psychiatry Duncan Maanillan House Porchester Road Nottingham. NG3 BAA UNITED KINGDOM
Dr. William McFarlane Maine Medical Center Department of Psychiatry 22 Bramhall Street Portland. ME 04102 USA
Dr. Patrick McGorry University of Melbourne Department of Psychiatry Locked 8ag 10 Parkville Victoria 3052 AUSTRALIA
Dr. Diana Perkins University of North Carolina Neuroscience Hospital Department of Psychiatry Chapel Hill. NC 27599-7160
Dr. Raimo K. Salokangas University of Turku Department of Psychiatry PL52 FIN 20521 Turku FINLAND
Dr. Heinze Hafner Central Institute of Mental Health Durchwahl 17 03-726 J568159 Mannheim GERMANY
Dr. Jan Olav Johannessen Rogaland Psychiatric Hospital Box 1163 Hillevag 4004 Stavanger NORWAY
Dr. Jan LibiQer Psychiatric Center Prague Ustavni 91 Praha 8-Bonice CZ-181-03 CZECH REPUBLIC
Dr. Tom McGlashan Yale Psychiatric Institute 184 Liberty Street New Haven. CT 06519 USA
Dr. Samoff Mednick University of Southern California Social Science Research Institute University Park 851 Los Angeles. CA 90089-0375 USA
Dr. Gary Remington Clarke Institute of Psychiatry 250 College Street. 111h Floor Toronto. M5T 1R8 CANADA
Dr. Jean Addington Foothill Medical Centre Department of Psychiatry 1403-29 Street Calgary. Alberta T2W 2T9 CANADA
Dr. Judit Harangozo II,wakenings Foundation <alvaria ter 5 -i-1083 Budapest -iUNGARY
Dr. Jiri Horacek :>rague Psychiatric Center Jstavni 91 181 03 Praha 8 Bohnice :;ZECH REPUBLIC
Dr. Bartosz Janikowski Psychiatricka leeebna Bohnice Ustavni 91 181 02 Praha 8 CZECH REPUBLIC
Dr. Marga Kocmur University Psychiatric Hospital Outpatient Services 1000 Ljubljana Njegoseva4 SLOVENIA
Dr. Don Linszen Adolescenten Kliniek AMClDe Meren Tafelbergweg 25 1105 BC Amsterdam THE NETHERLANDS
Dr. Michael Marsalek Mental Hospital Ustavni 91 Praha 8 Bohnice 181 02 CZECH REPUBLIC
Dr. Ross Norman London Health Science Center Department of Psychiatry Room 1138 392 South Street WMCH London, Ontario N6A-4G5 CANADA
Dr. Sheilagh Hodgins Universite de Montreal Department of Psychology C.P. 6128, Succ. Centre-Ville Montreal, Quebec H3C 3J7 CANADA
Dr. Peeter Jaansen Tartu University Psychiatric Hospital Raja 31 EE 2400 Tartu ESTONIA
Dr. Matcheri Keshavan Western Psychiatric Institute & Ciinic 3811 O'Hara Street Pittsburgh, PA 15213 USA
Dr. T. K. Larsen Researcher in TIPS Rogaland Psychiatric Hospital Armauer Hansensv 20 N-4016 Stavanger NORWAY
Dr. Dragos Marinescu Clinical Hospital No 3 Craiova Calea Bucuresti No. 126 1100 Craiova ROMANIA
Dr. Tandy Miller Yale Psychiatric Institute 184 liberty Street New Haven, CT 06519 USA
Dr. Virginija Novak Grubi Psihiatricna Klinika Studenec48 1260 Ljubljana SLOVENIA
255
256
Dr. Erika Perczel Awakenings Foundation Kalvaria ter 5 H-1083 Budapest HUNGARY
Dr. Jiri Raboch University Karlovy PSchiatricka Klinika Ke Karlovu 12802 Prague 2 CZECH REPUBLIC
Susan A. Stack University of Southem California Social Science Research Institute University Park 8-51 Los Angeles, CA 90089-0375 USA
Dr _ -Jarornir Svestka Faculty Hospital University Psychiatric Department Jihlavaka Street 20 63900 Brno CZECH REPUBLIC
Dyanne E. Van Peter University of Southern California Social Science Research Institute University Park B-51 Los Angeles, CA 90089-0375 USA
Dr. Svetlozar Vassilev University Psychiatric Clinic Section of Social Psychiatry 1 G. Sofiiski Street 1431 Sofia BULGARIA
Dr. Petr Zvolsky First Medical Faculty of Medicine Charles University Department of Psychiatry Ke Karlovu 11 12801 Praha 2 CZECH REPUBLIC
Dr. Boisteanu Petru Sp. CliniC de Psihiatrie Socola Str. Bucium No. 36 lasi ROMANIA
Dr. Erik Simonsen Inst. Of Personality Theory & Psychopathology Amtssygehuset Fjorden Smedegade 16 Dk-4000 Roskilde DENMARK
Dr. Teodora Stoeva University of Sofia Department of Social Psychology Bul. Evlogy Georgiev, 56 1124 Sofia BULGARIA
Dr. Kay Thomas Wolston Park Hospital Wolston Park Road WACOL Queenland 4076 AUSTRALIA
Dr. Veiko Vasar Tartu University Psychiatric Hospital Raja 31 EE 2400 Tartu ESTONIA
Dr. Robert Zipursky Clarke Institute of Psychiatry Schizophrenia Division 250 College Street Toronto M5T 1R8 CANADA
Subject Index
ABC Schizophrenia Study, 77, 78, 95 Acute care, 125 Acute psychosis, 114, 115,118 Adjustment disorders, 130 Adolescence, late,
affective development in, 207 cognitive development in, 206 depression in, 207 developmental tasks in, 206 neocortex development in, 206 prefrontal cortical deficit in, 207 prodromal period in, 207 psychotic predisposition in, 207 as risk period, 233
Affective disorder, 2,18,125,130,132, 152, 198, 199 Affective flattening, 85, 86, 243 Affective psychosis, 108 Affective symptoms, 79, 82 Aggressive behavior, 93 Agoraphobia, 128 Alcohol abuse, 93,95 Alcohol dependence, 63 Alloplastic personality disorders, 48 Ambient stress, 128 American Psychiatric Association, 27,43,174 Antidepressant medication, 140, 168, 205 Antioxidants, 239, 240, 241, 246 Antipsychotic treatment, 96, 140, 152, 182,198,205,233,234
atypical, 115 low-dose therapy, 116, 127, 169, 173, 176, 186, 187, 189, 214,215,223 medications, 167-176, 183-188, 190 side effects of, 170-172
Antisocial behavior, 93 Anxiety disorders, 130 Apoptosis, 236, 245 Assertive Community Treatment (ACf),211
257
At-risk group, III At-risk prodromal states, 56, 58,103, 105, 107, 136 Attenuated Positive Symptom Prodromal State, 138 Attenuated psychosis, 55, 56 Attenuated symptoms, 102, 107, 136-138,140,214 Auditory hallucinations, 80, 81 Autoimmune disorder, 236 Autonomic nervous system
responsiveness of, 49 Baseline risk,
of disorder,24 Basic Symptom Concept, 54, 73, 109 Behavior dimensions,
adolescent, 22 externalizing, 11,13,19 internalizing, 11,13, 19
Beck Depression Inventory (BOI), 126 Biological disposition, 183 Biopsychosocial assessment, 126 Biosocial Hypothesis, 199 Bipolar disorder, 101, 138, 169, 182, 200-202,204,205,211 Birth complications, 31,32,38,39,41 Bonn Scale for the Assessment of Basic Symptoms (BSABS), 5172, 75 Brief Psychiatric Rating Scale (BPRS), 107-109,138,170,191,212 Brain,
changesin,232,234 frontallobe,51,234 functional abnormalities in, 183 hippocampus, 111, 118,232 prefrontal cortex, 51, 57 reduced volume, 51, 57, 232 in schizophrenic patients, 51 structural abnormalities in, 183
temporal cortex, 58 temporal lobe, 51, 234 volume, 109, 110, 112, 118
Brief Intermittent Psychotic Prodromal State, 138, 139
258
Brief Limited Intermittent Psychotic Symptoms (BLIPS), 107, 108 Buckingham Project, 124, 128,212 Camarillo County Study, 185 Cannabis dependence, 109 Caregiver morbidity, 128, 129 Catatonia, 149 CATEGO,91
depression, 84, 86 Causal models, 204
longitudinal dimension in, 19
Central nervous system (CNS), 51, 52, 57,168,174 Cerebral deficits,
in schizophrenics, 51 in relatives of schizophrenics, 51
Charing Cross Health Index (CXD), 129 Childhood risk factors,11 Chlorpromazine, 171, 186, 198 Chlorproxithene, 189 Chlothiapine, 189 Clozapine, 171,172,175, 184, 185, 188-191,244
agranulocytosis in, 185 Clinical management, 131 Clinical morbidity, 128, 129 Cognitive Behavioral Marital and Family Carer Strategies, 127 Cognitive deficits, 95, 201, 205 Cognitive,
disturbance, 232 dysfunction, 202 function, abnormalities in, 204 impairment, 243 symptoms, 181
Cognitively Oriented Psychotherapy for Early Psychosis (COPE), 216, 222 Community Health Record of Risk Factors, 126 Comprehensive Assessment of Symptoms and History (CASH), 107, 108 Conceptual disorganization, 65, 107, 139,144, 150
Cortical serotonin receptors, 62 Cortisol levels, 118 Copenhagen High Risk Project, 29, 33, 48,72
DSM-III-R,31 Prediction of Schizophrenic Outcome by Premorbid Factors, 39
Cox proportional hazard model, 109 CSF volume, 52 Current And Past Psychopathology Scale (CAPPS), 30 D2 antagonists, 172 D2 blockade, 172, 174, 175 D2 receptors, 186, 187, 189 D2 occupancy, 172-174, 186 DEEP Project, 47,56,57,58,60,65 Deficit symptoms, 187,214 Delusional disorder, 155 Delusions, 81,108,137,143,144,150, 182
paranoid, 80 Depression, 83-86, 95, 96, 105,139, 140,149,168,198,203,204
depressive disorders, 131,211 depressive episodes, 83 depressive mood, 81, 83 depressive symptoms, 81-86, 109 depressive syndrome, 86, 87 in patients' family members, 204
Developmental anomalies, 74, 88 defects, 199 delay, 17,54 disability, 108 milestones, missed, 17, 54 predictors, 2
Deviant behavior in adolescent schoolchildren, 34
Dex-fenfluramin, 191 Diagnostic and Statistical Manual, revised third edition (DSM III-R), 30, 60,74,106,129,130, 152, 158
Diagnostic and Statistical Manual, revised fourth edition (DSM-IV-R), 63, 64, 108, 110, 137, 138, 181 Disability Assessment Schedule (DAS), 75,87,93 Discriminant function analysis (DFA), 35-40 Discrimination/prediction performance, 15 Disorganized symptoms, 138, 142, 143, 147, 150 Dissocial behavior, 93 Dopamine,183, 240, 246
activity, increased, 57 receptors, 183,239
Dopaminergic dysfunction, 183 Drug interventions, 128 Duration of Illness (DUI), 152 Duration of Untreated Psychosis (DUP), 71,72,152,153,155,156,160,163,198, 233 Dysphoric mood, 149,150 Early Detection, Intervention, and Prevention (EDIP), 215 Early illness, 77, 81, 83, 89, 92 Early intervention, 72, 96, Ill, 113, 117,119,123-125,132,136,139,152-154,158,167,184,198,200,205,210, 212,215-218
family intervention, 205 during neurodevelopment, 168 mental health services, 123, 124 primary care, 123-125 outcome evaluation, 123
Early Psychosis Assessment Team (EPAT),213 Early Psychosis Prevention and Intervention Center (EPPIC), 117, 153, 213,222 Early response genes, 189 Early signs questionnaire, 126 Eating Attitudes Test (EAT), 126 Educational attainment data, 25
Emotional response decreased, 146, 150 lack of, 146
Environmental changes, 110 factors, and risk of
schizophrenia, 231, 232 family, 130 marital, 130
259
stressors, 32,34, 56, 125,232 variables, 205
Epidemiology, 47 Executive functions, 51, 62 Expressed Emotion (EE), 201, 209, 212, 220
and relapse reduction, 212 Extrapyramidal symptoms (EPS), 170-174, 186, 188, 189 F N-methylspiro-peridol, 191 Family-aided Assertive Community Treatment (FACT), 198,211,215 Family history, 125 Family intervention, 200, 212, 223 Family Psychoeducation (FPE), 199, 200,211
and reduction in relapse, 211 Finnish Adoptive Family Study of Schizophrenia, 49 First-degree relatives, 106, 107 , 138, 140,145,231
of schizophrenic patients, 47, 58,59,60,61,63,64
alcoholism in, 48 schizophrenia in, 213 schizo typal personality
disorders in, 48 First episode psychosis, 110, 113, 152-154,167-169,173-176,197,199,200, 214
pharmacotherapy in, 167, 169 First episode schizophrenia, 151, 154, 155,181-184,186,190,203,210,233, 241
low-dose treatment in, 190 subtypes of, 190
Fluphenazine, 173
260
Frank disorder, 110 Frank psychosis, 53, 56, 72, 101-103, 108,176,215 Frank schizophrenia, 102 Free radicals, 237, 238, 240, 241, 245, 246
and cell function, 238 and polyunsaturated fatty acids
(PUPA), 238 and DNA, 238 and dopamine receptors, 239
Functional decline, 153 deficit, 197, 198 deterioration, 168,221 disability, 136,208,215
Functional impairment, 75, 87, 93, 115, 152 Functional Magnetic Resonance Imaging (FMRI), 57, 62 Functional deficits
in schizophrenic patients, 50 GABA system, 114 Generalized Anxiety Disorder, 65 General practitioner, 154, 157, 158, 162-164,213 General symptoms, 138,142,143, 148, 150 Genetic predisposition, 62-65
Genetic risk, 21,24,25, 29-32,34, 38-41, 72,136-138,140,199,231,236
and deterioration Prodromal state, 138, 140
and difficulty with executive functioning, 50
and memory difficulties, 50 and psychotic reactions, 51
Genotype, 235 Gestational disruption, 32 Global Assessment of Functional Ability (GAp), 61, 63-65,107, 109, 138-140,159,160,214 Global Assessment of Functioning Scale (GAS), 72 Glutamate receptors, 241, 242, 244, 245 Glutamatergic dysfunction, 241, 245
Grandiosity, 137, 144, 150 Hallucinations, 137, 144, 150, 182,243
auditory, 80, 81 Hamilton Rating Scale for Anxiety, 126 Hamilton Rating Scale for Depression, 126 Haloperidol, 108, 171-175, 186-191
and prolactin response, 191 Hayling Sentence Completion test, 50 High-risk group, 5,10,21,22,30,34,47, 48,49,72,108,109,116,125
Copenhagen study, 30,31,32,33,35,36,39,41
for psychosis, 52 lower IQ in, 50 reduction in executive
function, 50, 51 schoolchildren in England,
Scotland, and Wales, 5, 10 subjects who developed
schizophrenia, 35 timid daydreamers in, 10, 20,24
High Risk Project Copenhagen, 29,33 Israeli, 34, 72 New York, 35, 72,105 OB Copenhagen, 40
Hippocampus structural changes in, Ill, 118 volume of, 109,110, 112, 118
Home-based Intensive Care, 127 Hybrid/Interactive model, 55, 56 Hypothalamic-Pituitary-Adrenal Axis (HPA-Axis), 118 ICD-lO criteria, 82,181 Immune dysfunction, 236, 237 Impaired social behavior, 89 Incipient psychosis, 80, 86, 207 Indicators of risk,
familial, 96 neuropsychological, 96 neurobiological, 96
Instrument for the Retrospective Assessment
of the Onset of Schizophrenia (IRAOS), 53 74-78, 81, 82, 87, 93 Integrated Mental Health Service, 129, 130, 131 International Classification of Diseases, eighth revision (ICD-8), 30 Intervention
clinical, 128 early, 72, 96,111,113,119, 123-125 pharmacological, 115 premorbid 29,35,39,41 preventive, 42, 115 psychopharmacological, 42 psychosocial, 42 targeted, 126 therapeutic, 127, 128
Israeli High Risk Study, 34, 72 Late fetal development, 232, 245 Latent psychotic trend, 48 Latent trait analysis, 10, 13, 23 Lifetime History of Neuroleptic Treatment, (LHNT), 61 Living Skills Training, 127 Logistic regression models, 15,23 Low-risk group, 29, 30
in Copenhagen study, 30, 31, 32,37,41 schoolchildren, 49
Magnetic Resonance Imaging (MRI), 57,62,110, 111, 118,234 Magnetic Resonance Spectroscopy, 111 Manic depressive disorder, 161 Markers for psychosis,
biological, 115 milestone achievement, 111 neurocognitive functioning, 111 neurological abnormalities, 111 obstetric complications, 111 poor premorbid adjustment, 111
Mauritius study, 42 ANS hyperresponders in, 42 preschool intervention in, 42
Membrane phospholipid model, 114 Medical morbidity, 132 Medications,
261
antidepressant, 140 168,205 antipsychotic, 140, 152, 167-169, 183-188, 190, 198,205, 233,234 antixiolytics, 168 chlorpromazine, 171, 186, 198 chlorprothixene, 189 c1othiapine, 189 c1ozapine, 171, 172, 175, 184, 185,188-191,244 dex-fenfluramin,191 fluphenazine, 173 F N-methylspiro-peridol, 191 haloperidol, 108, 171-175, 186-191 neuroleptic, 108,113, 117, 151, 152, 184-187, 189, 191, 192, 213,240,241 olanzapine, 156, 170-172, 189, 223,244 PCP, 242-245 perphenazine, 156, 188, 189 phenothiazine, 184 psychotomimetics, 243 psychotogenic lysergic acid
(LSD), 191,243 quetiapine, 172, 175,223 risperidone, 116, 156, 170-173, 186, 188, 189 thioridazine, 189 zuc1openthixol, 188
Mental health enquiry (MHE), 3 Mismatch negativity, (MMN), 57 Milestones,
achievement of, 109, 111 of evolving disorder, 75 missed, in English
schoolchildren, 17
262
Mitochondrial function, 235, 236 Modular Present State Examination, 126 Motor disturbances, 149, 150,232 National Survey of Health and Development (NSHD), 2,3,4,18,23,25 NARSAD,65 N-methyl-D-aspartate (NMDA), 242-247 NMDA receptor hypofunction (NRH), 243-246 Negative psychopathology, 138 Negative symptoms, 75-87, 93,104, 113, 140, 142-145, 150, 152, 173, 181, 186-188,200,203,208,220,221,243, 244,247 Negative-symptom schizophrenia, 49 Negative syndrome, 86, 87 Neurocognitive variables, 109, III Neurodevelopmental
defects, 204 deficits, 221 mechanisms, 247 variables, 109, 110
Neurobiology, 118, 199,247 Neurochemistry, 192 Neurodegeneration, 168, 176,236,237, 240,245-247 Neurodegenerative
disorder, 235 hypothesis, 233, 245, 246
Neurodevelopmental hypothesis, 232, 246 Neuroendocrinology, 192 Neuroimaging, 47, 51, 56, 62,172,192 Neuroimaging examinations, 62, 109, 234
cortical serotonin receptors, 62 Functional Magentic
Resonance Imaging (FMRI), 62 Magnetic Resonance Imaging
(MRI), 57, 62, 234 Positron Emission
Tomography (PET), 57, 62
Neuroleptic medication, 108,113, 117, 151,152,184-187,189,191,192,213, 240,241 Neuroleptic response, 190 Neuroleptic therapy,
atypical, 117 Neuromotor parameters, 72 Neuron loss, 153 Neuronal cell death, 235-241, 245, 246 Neurophysiology, 56, 62 Neurophysiological examinations, 62
Mismatch negativity (MMN), 62 P300,62 Transcranial Magnetic
Stimulation-High Resolution EEG ,57, 62 Neuropsychological test battery, 62
California Verbal Learning Test (CVL T), 62
CPF,62 CPF-Delay,62 Distraction, 62 Verbal Fluency Test, 62 WAIS-R,62
Neuropsychology, 47, 50, 56, 61, 62, 72 New York High Risk Project, 35, 72,105 NIMH,42 NMDA hypothesis, 114 Non-paranoid schizophrenics, 36 Non-specific symptoms, 75-80, 104 OB Copenhagen High Risk Project, 40 Obsessive-compulsive disorder, 65, 128 Olanzapine, 156, 170-172, 189,223, 244 Oxidative stress, 237, 239, 240, 245, 246 Panic,149 Pan-neurosis, 48 Past History and Sociodemographic Description Schedule (PHSD), 75 Paranoia, 137, 139, 143,201,243 Paranoid delusions, 80 Paranoid Personality Disorder, 63, 182 Paranoid schizophrenics, 35,36
Perceptual abberation scale, 51 Perceptual abnormalities, 137 Perinatal complications, 109 Perinatal damage, 49 Peripsychosis, 1, 12, 25 Perphenazine, 156, 188, 189 Personal Assessment and Crisis Evaluation (PACE) Clinic, 103-105, 109,110,115-117,213,214 Personality Disorder Questionnaire (PDQ), 61, 63-65 Pharmacotherapy, 167, 169, 181 Phenothiazine, 184 Phenotype, 235 Placebo treatment
medication, 117 psychological, 117
Positive and Negative Symptom Scale (P~SS),61,63,65, 138, 155, 158-160,162,170,173 Positive symptoms, 75-83, 86, 93, 104, 137,138, 140, 142, 143, 150, 152, 168, 173,200,214,221 Positive -symptom schizophrenia, 49 Positron Emission Tomography (PET), 57,62,172-174,189 Posner-test, 51, 62 Post-psychotic phase, 114 Precursors of schizophrenia
behavioral, 33 CNS deviances, 52 dispositional, 33,34 impaired social behavior, 89
Prediction models, 18,35,41,93 Predictors,
adolescent, 2 childhood, 2 depression, 86 depressive symptoms, 84 developmental, 2 early illness, 76, 77,83 hippocampal volume, 110 neuroimaging examinations, 57
neuropsychological examinations, 57, 61, 62
neourophysiological examinations, 57
of psychosis, 109 poor affective control, 49
Premonitory symptoms, 74
263
Premorbid Adjustment Scale (PAS), 61, 63,64,65,75,125,160 Premorbid functioning, 118 Premorbid indicators, 33,34,36,39,40, 49,74, 151, 152 Prepsychotic, 21,25, 53, 58,101-103, 114, 115, 118, 151, 153,208,224 Preschizophrenic, 33, 35, 37-39,50,51
boys, 34, 48,49 girls, 35, 48,49
Present state examination (PSE) 3,4, 30, 75,93,125,129
modular, 126 Prevention paradox, 22 Preventive intervention, 57,103,117 Primary care, 53, 125, 131, 153, 158, 214 Primary personality disorders, 130 PROD, 58, 59, 63, 60, 61, 62, 63, 64 Prodromal change model, 55 Prodromal constellations, 135 Prodromal phase, 52, 71, 74-77, 80, 86-89,94,95,101,104,106,114,151, 153,197-201,203,206,208,212,215, 216,224
intervention during, 52, 136, 198 length of, 52 stigma during, 201, 202, 210
Prodromal psychosis, 197,205 Prodromal Signs Checklist, 126 Prodromal state, 118, 126, 132, 136-141,151,202,214,218,220,224 Prodromal symptoms, 47, 52, 53, 57, 58,61,63,64,65,71,74,75,96,125, 132,136,137,151,153,158,198,204, 209,217,222
264
Prodromal treatment, 136 Prodrome of psychosis, 52, 53, 55, 74, 104-106,113,118,168,176
basic symptoms in, 54 behavioral changes, 53, 54, 56 initial, 53 hyperfunction in, 53 hypofUnction in, 53 intervention during, 169 reactive symptoms, 56 relapse, 53 attention defects in, 54
Program of Assertive Community Treatment (PACT), 224 Pseudoneurotic schizophrenia, 48 Pseudopsychotic,35 Psychiatric morbidity, 132 Psychiatric and Personal History Schedule (PPHS), 75 Psychoeducation, 208, 212 Psychoeducational model, 216 Psychoeducational Multi-family Group (PE~G),211,214,216,220,223,224
Psychological Impairments Rating Schedule (PIRS), 75, 93 Psychological treatment, 117 Psychopathology, 138
disorganized, 138 general, 138 negative, 138
Psychosis threshold, 137 Psychosocial
disorders, 130, 204 fUnction, 233 intervention, 224 stress, 199 treatments, 115, 117,204,214, 224
Psychotic break, 140 Psychotic disorder, 63,101,131,162, 197,199,200,210,215,217,218,224 Psychotic episode, 71-75, 77-80, 84, 85, 108,220,223,246 Psychotic prephase, 76, 77
Psychotic phase, 153 Psychotic state, 135, 136, 198 Psychotic symptoms, 71-75, 79,86,93-96,109,158,168,169,197,205,217, 223
genetic vulnerability to, 51 thought disorder, 80, 81,137, 182,223
Psychotogenic lysergic acid (LSD), 191, 243 Psychotomimetic effect, 244-246 Quality of Life Scale (QLS), 61, 63, 64 Quantitative EEG (QEEG), 57 Quetiapine, 172, 175, 223 Rearing enivironment, 34,36-38,41,49 Risk factors,
state, 109 trait, 109
Risperidone, 116, 156, 170-173, 186, 188, 189 Rivermead behavioral memory test, 50 ROC models, 15,23 Role functioning,
deterioration in, 147, 150,206 Scale for the Assessment of Negative Symptoms (SANS), 75, 85, 86, 93, 109 Schizoaffective disorder, 155, 182 Schizophrenic outcome, 31, 35 Schizophrenic predisposition, 32, 34 Schizophreniform disorder, 190 Schizotypal personality disorders, 48, 106, 107, 138, 139, 155, 181 School behavior, 37,38,40,41 Scale of Prodromal Symptoms (SOPS), 135-142,150 scm, 61, 63, 64,160 Serotonin-dopamine antagonists, 187, 189 Serotonin receptors, changes in, 57 Sexual dysfunction, 130 Single Proton Emission Topography (SPECT), 172, 174 Sleep disturbance, 148, 150 Social course, 91-93 Social
adjustment, 160
disability, 75, 87, 93, 95, 96, 128 decline, 88,94, 168 disadvantage, 88, 89 isolation, 199,202,203,220 network, 210, 220 overadaptiveness, 93 role performance, 89-95 stagnation, 88, 94 withdrawal, 79, 80, 87,145, 204,206,215,243
Social morbidity, 129 Social Stagnation Hypothesis, 88 Socially adverse behavior, 93, 94 Somatization, 130 Stadium melancholicum, 86 Standard treatment protocol, 156, 159 Stepwise regression, 9,24, 93 Stress-vulnerability model, 118 Structural Interview for Prodromal Symptoms (SIPS), 58-61, 63-65, 135-139,141 Substance abuse, 93, 95, 96, 125, 130, 160,168,198,201,215 Subthreshold syndrome, 103, 105 Suicide
attempted, 81, 82 risk of, 82 thoughts of, 149
Suicide risk checklist, 126 Superoxide dismutase (SOD), 238, 240, 246 Symptom Check List (SCL), 61, 63, 65 Tardive Dyskinesia (TD), 171, 176, 185,241 Teacher questionnaire, 4
analysis, 5, 10 milestones, 5 results, 6
Teacher reports, Schoolchildren, characteristics of, 7 categorical data, 12 combined developmental
aspects of risk, 17
265
Thiobarbituric acid reactive substances (TBARS),241 Thought disorder, 80, 81,137, 182,223 Timid daydreamers, 54
as high-risk group, 21 as predictors of schizophrenia, 21,54
TIPS Project, 151, 154-157, 163, 164 Thioridazine, 189 Trait criteria, 72 Transition to psychosis, 110,113,116 Treatments,
biological, 115 medical, 117 psychological, 117 psychosocial, 115,117,204, 214,224
Transcranial Magnetic StimulationHigh Resolution EEG (TMS-HR-EEG), 57,62 Twin studies, 231 Ultra high-risk group, 105, 109, 110, 113, 114, 116, 118 Untreated psychosis, 71, 72 Withdrawal, 139, 145, 150,243 Working memory, difficulty in, 51 World Health Organization (WHO), 43, 203 Zuclopenthixol, 188
Name Index
Abdalla, D.S., 250
Achiron, A., 249
Ackenheil. M., 249
Adamo, V.H., 120
Adams, B., 251
Adams, M.E., 180
Addington, D., 99
Addington, J., 99
Adlard, S., 121,122,178
Adler, L.E., 250, 251
Agarwal, S., 249
Alanen,Y.O., 47,48, 65
Allebeck, P., 28, 248
Allen, A.J., 249
Alliger, R., 247
Alpert, M., 88,99
Altamura, 186,193
Alvir, J.M.I., 44, 68, 97, 119, 165, 177,
179,180,248,249
Amano, M., 251
Ameli, R., 67
Amico, E., 251
Amin, S.,66
Amsler, 185,193
Anand, A., 251
an der Heiden. W., 96-100.119,120.
177
Anderson, C.M., 133, 216, 228, 230
Anderson, Y., 66
Andreasen, N.C., 98, 120, 177, 247
Andrews, P.I., 249
267
Anis, N.A., 250
Annable, L., i178
Anwyl, R., 250
Arancio, 0., 250
Arean, P., 228
Arenal, A., 100
Arndt, S., 120, 177,248
Aronen, H.J., 67
Asensi, M., 251
Asnis,L., 65
Atkins, E., 26
Aubrey, A., 44, 98
Auerbach, J.G., 44, 98
Ayd, F.I., 193
Baker, R.W., 178
Ba1dessarini, R.I., 173,179
Balter, M.B., 133
Baron, 48, 68, 65
Barr, C.E., 43, 44
Barrowclough, c., 133
Barouche, F., 179, 195
Bartko, G., 180
Bassett, A.S., 97, 120
Batinic-Haberle, I., 250
Baucom, D.H., 229
Baum, K.M., 50, 65
Bauer-Schubart, C., 98
Beasley, C., Jr., 178, 195
Bean, G., 179
Beau, M.M., 249
Bebbington, P., 119, 201,226,228
268
Bechara, E.J., 250
Beck, A.T., 126, 127,133
Becker, T., 227
Bedford, A., 82,86,99
Bedwell, J., 119,249
Bell,M.,44
Bell, R.Q., 120
Bell, W.R., 250
Bellack, A.S., 134
Beiser,M., 53, 65, 67, 97,152,165, 179
Benes, F.M., 179
Bennett, J., 180
Bergman, H., 227
Bergman, J., 67
Berisford, M.A., 178
Berkovic, S.F., 249
Berkowitz, R., 134
Berman, R.M., 251
Berner, W.,l00
Berry, S.C., 250
Bertha, E., 193
Betz, N .E., 44
Bickford, P., 250
Biegel, D.E., 228
Biehl, H., 98, 99
Bigelow, L.B., 177
Bilder, R.,l00, 177.180
Bilker, W., 248
Birchwood, M., 99. 119, 165,225
Birley, J.L.T., 226
Bittigau, P., 251
Blanchard, J.e., 250
Blazer,D., 132
Bleuler,47
Blumenthal, J., 119,249
Blyler, e.R., 227
Bockaert, J., 250
Bohme, G.A., 250
Boix, J., 251
Bollini, P., 180
Bon, C., 250
Bonnet, D., 43
Borenstein, M., 177. 248
Borg, D.C., 249
Borges, K., 250
Borison, R.L., 194
Bosch, F., 251
Bowers, M.B., 250
Bowie, D., 250
Boyd,J., 230
Brammer M., 121
Brandt, L., 28
Brar, J.S., 249
Brauzer, B.,180
Bravin, J., 122, 178
Brecher, M., 178
Bredt, D.S., 250
Breier, A., 187,193,250,251
Bremmer, J.D., 250
Brewer, W., 66,121
Brewin, C., 226
Bridle, N.,121
Brodie, J.D., 179
Bromet, E.J., 99, 178, 227
Brooks, V.G., 178
Brown, A.e., 133
Brown, B.S., 133,
Brown, G.W., 201, 226-228
Brugha, T.S., 178, 228
Bryne, M., 66
Bubeck, B., 180
Buchanan,R.W., 187,193
Buckley, P.F., 121, 248
Buka, S.L., 26
Bullmore, E.T., 121, 177
Burke, J.D., 133
Burks, E., 178
Burman, B., 43
Burman, M.A., 132
Bums, BJ., 133
Burrows, G.D., 68
Burton, N.R., 250
Bustamante, S., 97
Buzina, R., 250
Byrd, S.L., 179
Cadet, J .L., 249
Caligiuri, M.P., 178
Cameron, D.E., 53, 66
Campbell, G., 250
Cannon, M., 26, 248, 249
Cannon, T.D., 41,43,44,48,51,52,66,
68,97,248
Cantor-Graae, E., 121
Cappiello, A., 251
Capri, S.,225
Cardenas, e., 178
Cardno, A.G., 248
Carlen, P.L., 251
Carlson, G., 178
Carlsson, A., 251
Carlsson,M.L., 251
Carman,J., 188,193
Carpenter, W.T., 127,134,160,165,
187,193
Carter, J.W., 29,44
Casey, D.E., 178, 180,184,193
Castle, DJ., 248
Cauley, K., 249
Cerri, A., 66
Chafetz, L., 228
Chakos, M., 177, 179, 180,248,249,
251
Chalmers, T.e., 180
Chapman, J.P., 54, 66,136, 141
Chapman, L.J., 141
Chapman, P.F., 250
Charbonneau-Powis, M., 134
Charney, D.S., 250, 251
Chengappa, K.N.R., 178,249
Cherry, N., 26
Choquet,M., l00
Chouinard, G., 178
Christensen, B.K., 180
Christensen, J., 249
269
270
Christie, S., 179
Chuang, D.M., 249
Chung, L.c., 251
Cicchetti, D., 225
Clark, D.H., 53, 66
Clement, M.V., 251
Clements, B.A., 66
Clifton, A., 251
Coakley, G., 177
Cocharne, 165
Cohen, B,M., 179
Cohen, C.I., 227
Coid, B., 248
Cole, D., 178
Cole, J.M., 184,193
Collins, P.F., 193
Condray, R., 226
Conrad, K., 99
Cook, M., 121
Cooper, J.E., 27, 98, 133
Cooper, T.B., 179, 195
Copolov, D., 66,121
Coppens, H.J., 179
Comblatt, B.A., 44, 97, 120
Correnti, E.E., 250
Cotton, P., 179
Cosgrave, E.M., 122, 178
Coverdale, J.H., i166
Cowell, P., 248
Cox, 109 (???)
Coyle, J.T., 250,251
Craig, T., 178
Crain, B., 249
Crapo, J.D., 250, 251
Creese, I., 180
Croudace, T.J., 1
Crow, TJ., 26,44, 68, 72,97,119,
133,152,165,225
Crump, N.H., 121
Cuesta Nunez, M.J., 100
Cu1casi, M., 250
Cullen, F.T., 226
Curti, D., 249
Czobor, P., 194, 195
D' Adamio, L., 249
Dalais, c., 44
Daly, D., 251
Dahlqvist, R., 179
Das, I., 250
Das, M.K., 228
Das Gupta, F., 249
DaSilva, J., 179
Daskalakis, Z.J., 179
David, A.S., 28, 121, 248
Davidson, L., 135
Davidson, M., 193
Davies, N.J., 248
Davis, J.M., 180, 184, 191,193
Davis, K.L., 193
Davis, W.W., 120
Dawson, T.M., 250
Dawson, V.L., 250
Day, BJ., 250, 251
Deakins, M.D., 166, 230
De Koninck, 252
Delaney, R., 250
De la Varga, M., 100
DeLisi, L.E., 100,248
Demisch, S., 180
Depue,R.A., 183,193
Deshimaru, M., 250
De Smedt, G., il78
Desmond, P., 121
Dichter, M.A., 249
Dikranian, K., 251
Dilling, H., 133
Dingledine, R., 250
Dixon, WJ., 194,248
Doble, A., 250
Dobscha, S., 57, 67
Docherty, J.P., 82, 86,99
Doddi, S., 194
Domesick, V.B., 180
Done, DJ., 26, 98
Doneshka, P., 67
Dopfner, M., 100
Doraiswamy, P.M., 179
Doran, A.R., 193
Douglas, J.W.B., 26, 27
Dow, S.,249
Dozier,M., 203,227
Draine, J., 227, 228
Dubbert, B.K., 249
Duckworth, K., 226
Dudgeon, P., 98, 121, 177
Duncan, G., 251
Dunham, H.W., 86,99
Dunn, L., 179
Dunne, E., 225
Durrell,J., 203,228
Dwork, A.J., 249
Dyck, D., 226
Eaton, W.W., 120
Eberlein-Vries, R., 134
271
Edwards, J., 26,97,119,133,154,166,
216,230
Ehrin, E., 179
Ekstrom, M., 44
Elman, I., 251
Emory, E., 43
Emsley, R., 178
Endicott, J., 165
English, C.W., 178
Ensel, W., 227
Erbas, T., 179
Erhart, S.M., 179
Erickson, D., 65, 97, 165
Erlenmeyer-Kimling, L., 44, 97, 120
Ermilov, M., 251
Eronen, E., 67
Escobar, J.L., 132
Espinosa, R., 249
Evans, A., 119,249
Fadden, G., 133
272
Falkai, P., 97
Falloon, I.R.H., 41,44,99,122, 123,
125-127,131,133,134,153,154,158,
164,166,211-213,224,229,230
Farber, J.L., 250, 251
Farde, L., 179, 189,193
Farkenheuer, B., 67, 98, 100, 120
Farmer, A.E., 248
Fegert, J.M., 100
Feinberg, J., 57, 66
Feldman, P.M., 44
Fennig, S., 99, 178
Fenton, W.S., 95,100,225,227
Ferrier, I.N., 249
Fertig,M.K., 178
Fernandez, T., 119, 249
Fibiger,H.C., 189,193
Fikuda, M., 68
Fischer, I.A., 248
Fish, B., 97
Fiszbein, A., 142, 166
Fix, A.S., 251
Flach, K., 250
Flaum, M., 120, 177, 247
Fleming, J.A.E., 65, 97, 165
Flynn, S.W., 97
Florijn, W.j., 180
Foerster, A., 119
Fog, R., 165, 178
Folnegovic, V., 250
Folstein,M.F., 133
Folstein, S.E, 133
Forslund, K., 179
Forster,MJ.,249
Foulds, G.A., 82,86,99
Fowler, J.S., 179
Frazier, J.A., 248
Francey, S., 66, 97, 121,122, 178
Frangou, S., 177
Frank, E., 229
Franke, P., 66
Frantseva, M.V., 251
Freedman, R., 250
Freeman, G.K., 250
Freeman, H.,88,99
Frenkel, E., 44
Fridovich, I., 251
Friedman, D., 97
Friis, S., 151
Friston, K.J., 194
Frith, C.D., 194
Frumin, M., 248
Fujino, H., 251
Fukuda, J., 251
Fuller, M.A., 179
Gahring, L.C., 249
Gaite, L., 100
Gallacher, F., 248
Gallo,JJ., 182,194
Ganguli, R., 249
Garcia de la Asuncion, J., 251
Gardner, C.O., 248
Gamer, 126
Garratt, L.S., 225
Garrison, V., 227
Garver, D.L., 180,184,193,194,249
Garvey, M., 249
Geddes, J.R, 44,180
Geider, F.J., 180
Geisler, S.H., 44, 68,97,100, 119, 166,
177,180,248,249
George, E.L., 229
George, L.K., 132
Gerlach, 1., 178, 186,193
Germano, D., 122, 178
Gershon, S., 180
Giedd, J.N., 119, 248, 249
Giel, R., 248
Gierl, B., 180
Gillham, J., 120
Gispen-de Wied, c.c., 248
Gliddon, A., 250
Glover, G., 248
Goff, D.C., 251
Gold, J.M., 50, 66
Goldberg, D., 133
Goldberg, S.C., 187,193
Goldberg, T.E., 50, 66,100,177
Goldman, C., 226
Goldman, H.H., 165
Goldman, R., 180
Goldman-Rakic, P.S., 248
Goldstein, D., 178, , 201, 211
Goldstein, J.M., 26.127,134
Goldstein, M., 226, 229, 230
Gonzalez, S.P., 217, 230
Gordon, C.T., 248
Gorham, D.R., 121,138, 142
Gottesman, 1.1., 43,120,248
Graham, D.G., 250
Graham-Hole, V., 134
Grant, E., 66
Grayson, D.S., 27
Grebb,185,193,194
Green, M.F., 165, 177,248
Griesinger, W., 86,99
Griffith, J., 180, 250
Grimson, R, 248
Grochowski, S., 67
273
Gross,G., 54, 58, 66,67, 68, 97, 98, 141,
165,177,248
Grove, W.M., 66
Gruber, R., 249
Gruen, R., 65
Gruenberg, A.M., 67
Grundy, S., i178
Gruzelier, J.H., 69
Grubb, T.W.
Gupta, S., 177
Gur, R, 66, 248
Gutknecht, W.F., 250
Gutkind, D., 44
Guvener, N., 179
Guy, W., 133
274
Guyatt, G.H., 27
Gwag, B.J., 251
Haaparanta, M., 67
Haas, G.L., 152,165,177, 198,225
Hafner H., 53, 58, 65, 66, 67, 71,96-
100,119,120,136,141 ,152,165,177,
247
Hagg, S., 179
Haggerty, R.J., 28, 120
Hain, c., 66
Haley, J.E., 250
Hall, H., 179
Halldin, C., 179
Hallgren, M.A., 121,122,178
Hambrecht, M., 67, 96, 98, 99, 120
Hamburger, S., 119, 248,249
Hamilton, M.,126, 133
Hamilton, N.G., 227
Hammett, E.B. 179
Hans, S.L., 44, 98
Hansen, V., 179
Hanslick, J., 251
Hansson, L.O., 251
Harcherik, D., 67
Hardt, J., 66
Hardy, J., 120
Hare, E.H., 248
Hargreaves, R.J., 251
Harikainen, A.L., 26, 98
Harrigan, S.M., 26, 97, 119, 133, 166
Harris, J.G., 250
Harris, M.J., 178,227
Harris, T., 227
Harrison, G., 66
Harrison, P.J., 248
Harrow, M., 99
Harvey, I., 121, 190
Harvey, P.D., 193
Hasegawa, M., 251
Haslam, N., 43
Hassan, M., 180
Havassy, B., 228
Hawkins, R.D., 250
Hayashida, S., 68
Hayden, D.L., 251
Haynes, R.B., 27
Hays, J.C., 228
He, X.P., 249
Helgason, L., 72, 97, 165,225
Heller, T., 227
Hearn, N., 122, 178
Heinemann, S.F., 249
Heinimaa, 141
Heinrichs, D.W., 127,134, 187,193
Heinssen, R.K., 227
Hemsley, D.R., 177
Henderson, A.S., 27
Heninger, G.R., 250
Heresco-Levy, U., 251
Herczeg, I., 180
Herrera Castanedo, S.,l00
Hersen, M., 134
Herz,126
Heston, L.L., 43
Hetts, S., 249
Hietala, 52,67
Hijman, R., 251
Hilder, W., 25
Hill, R.G., 251
Himmelhoch, J.M., 134
Hirayasu, Y., 248
Hirsch, S.R., 66, 69, 228, 250
Hirschowitz, J., 180
Hiramatsu, K-I., 68
Hoch, P.H., 48,67
Hodges, A., 66
Hoff, A.L., 100, 248
Hoffman, R.E., 67,135
Hogarty, G.E.,126, 127,133,180,194,
216,226, 229,230
Hollis, c., 48, 67
Hollister, J.M.,26, 43, 248
Hommer, D.W., 195
Honer, W.G., 97
Honigfeld, G., 194
Hooley, J.M., 226
Hoppes, E., 43
Hora ek, J., 194 (please verify spelling
on this one; it appears this way 2x)
Homeland, M., 151
Hough, R.L., 132
Houle, S., 179, 180
Hoult, J.,127, 134
Howard, R.J., 121
Hoyos, c., 121
Hubbard, W.c., 177
275
Huber, G., 54, 58,66, 67, 68, 72,96, 97,
98,109,141,151,165,248
Hughes, T.E., 249
Hulbert, 216
Hultman, C.M., 227, 228
Hurd, G., 227
Husby, R.,142
Huttenlocher, P.R., 57, 67
Huttunen, M.O., 25,26,43,66,187,
193, 248, 248
Huttunen, T., 26, 248
Huxley, P., 133
Hwu, H.G., 227
Hyde, A., 226
Hyde, T.M., 100, 177
Iacono, W.G., 65,66, 67, 97
Ikeda, K., 251
Ikeda, M., 251
Ikonomidou, c., 251
Ilmonieni, 57, 67
Ingraham, LJ., 44
Inoue, K., 165
Iqbal,N., 191 , 193
Ismail, B., 121
Isohanni, H., 98
Isohanni, M., 26
Iversen, L.L., 251
Iwasaki, K., 249
276
Izumi, Y., 250
Jablensky, A., 98
Jacobsen, B., 43,68,97
Jackson, D., 99
Jackson, HJ., 26,74,97,98,119-121,
133,166,177,216,230
Jacobsen, L., 248
Jane, J.L., 179
Janicak,P.G., 186,193
Janssen, P.M.F., 194
Janumpalli, S., 249
Jarvelin, M.R., 26
Jaskiw, G.E.,179, 248
Javaid, J.I.,193
Javitt, D.C., 250, 251
Jaycox, L.H., 120
Javitt,D.C., 52, 67
Jeffries, N.,l19, 249
Jeste, D.Y., 178
Jetovic-Todorovic, Y., 251
Joa,I.,151
Jody, D., 177, 248
Joelsson, L., 179
Johanessen, J.O., 119,136, 141,151,
153,164,165,166
John, R.S., 37,44, 68
Johnson, A.L., 44, 97, 119, 133, 165,
188
Johnson, D.A.W.,193, 227, 229
Johnstone, E.C., 26, 44, 66, 9,119,152,
165,180,225
Jokelainen, J., 26
Jones,C.,179,180,194
Jones, F., 66
Jones, K., 133
Jones, L.A., 248
Jones, P.B., 1,2,11,18,26,54,67,74,98,
119,121,177,248,249
Jones, S., 249
Jorgensen, A., 179
Jung, E., 98, 99
Jurjus, G.J., 179
Juul Povlsen, U.,178
Kahler, L.A., 249
Kahn,R.S, 191,193,248,251
Kajiwara, K., 251
Kaleva, M., 69
Kaljonen, I.H.A., 100
Kallmann, FJ., 43
Kamerow, D.B., 133
Kameyama, K., 68, 251
Kamoshita, S., 27
Karnran, A., 179
Kandel, E.R., 250
Kane, lM., 65, 127,134,165,176,178-
180,185,186,194,225
Kaplan, 185, 194
Kapur,S, 167,178-180, 186, 189,194
Karajgi, B., 194
Karayiorgu, M., 249
Karhu, J.,67
Karper, L.P., 250
Karr, M.l80
Katila, T., 67
Kato, N., 165
Katsanis, J., 66, 67
Katz, B., 179
Kaufman, M.A., 249
Kawachi, I., 227
Kay, D.W.K., 27
Kay, S.R., 138,142,166
Kaysen, D., 248
Keith, S.J., 211, 225, 248
Keitner, G.I., 230
Kelkar, H., 250
Kendler,H.S., 47, 48, 67, 68, 228, 248
Keshavan, S., 165
Kestenbaum, CJ., 120
Kiernan, K.E., 26
Kim, E.Y., 251
Kim, Y.H. 251
Kind, P., 133
Kingsbury, S.J., 249
Kinon, BJ., 251
Kinoshita, H., 251
Kinsella, A., 177
Kirby, e., 251
Kirch, D.G., 249
Kirkpatrick, B., 193
Kirvela, 0., 67
Kishida, E., 251
Kissling, W., 180
Kleinman, J.E., 100, 177
Klerman, G.L., 193
Klosterkotter,J., 51, 54, 58, 66, 68,
72,74,82,96,97,98,99,136,141
KO,G., 193
Kodama, H., 251
Koffel, B., 250
Koh, J.Y., 251
Kohr, G., 251
Kojo, Y., 251
Konicki, P.E., 179
Kopala, L.e., 97
Kopeikin, H., 230
Korbar, M., 250
277
Koreen, A.R., 166, 177, 179, 180,249
Koren, D., 26
Korf, J., 179
Kosky, R., 120
Kostakoglu, A.E., 170
Kostic, V., 249
Kottgen, C., 229
Koval, M.S., 179
Kovasznay, B., 178
Kraepelin, E., 47, 71, 82,96, 99, 151,
165,192
Kraude, W.H., 248
Kraus, J., 231, 249, 251,252
Krausz, M., 119
Krekorian, H., 122
Kreitshmann-Adermahr, I., 68
Kremen, W.S., 26
Kristbjarnarson, H., 249
278
Krumm, B., 98, 99
Krystal, J.H., 250, 251
Ku, H.H., 249
Kubota, A., 251
Kugelmass, S., 44
Kuipers, L., 134,201,226
Kulhara, P.L., 228
Kulkarni, 1., 230
Kumagai, J., 251
Kumar, N.G., 249
Kumra, S., 248
Kuoppamaki, M., 67
Kushner, M., 248
Kvebrek, R., 151
Kwapil, T.R., 141
Kysar, L., 178
Labruyere, J., 251
Lacana, E., 249
Lacro, J.P., 178
Lafton-Cazal, M., 250
Lahti, I., 69, 250
Laing, P., 43, 248
Laksy, K., 69
Lal,H.,249
Landerman, R., 132
Lange, N., 251
Lapointe, 1.S., 97
Laporta, M., 122
LaPorte, D., 250
Larsen, T.K.,141, 151, 152,166
Lavelle, J., 178
Lavori, P., 250
Lawrie, S.M., 44
Lebow, B.S., 66
Ledoux, S., 100
Lee, J.C., 194
Leff,J., 126,134,211,226,228,229
Letley, H.P., 227, 229
Lehman, A.F., 160,165,166,225,229
Lehmkuhl, G., 100
Lehmkuhl, U., 100
Leinonen,E., 68
Lemmens, P., 178
LeMoal, 183,194
Lenane, M., 119, 248, 249
Lenz, K., 100, 178
Leonard, H.L., 249
Leonard, S., 250
Lesage, A., 178
Levine, J., 229
Levinson, D.F., 249
Levitt, J.J., 248, 251
Lewine, R.J., 50, 69, 97
Lewis, D.A., 248
Lewis, G., 26,28, 248
Lewis, S.W., 119,248
Leysen,J.E., 189,194
Liberman, R.P., 133, 152
Lieberman, J.A., 44,68,97,100, 119,
127,153,165,166,177-180,225,132,
248,249,251
Libiger, J., 181,194
Licht, D.M., 226
Lichtenstein, M., 251
Liddle, P.F., 51,68,191,194
Lin,N., 227
Lin, S.P., 248
Lincoln, c., 154, 166
Lindelius, R., 97
Lindstroem,L.H., 185,194
Link,B.G., 201, 226, 227
Linz, M., 66, 67, 97, 248
Lipschutz-Broch, L., 100
Lipsitt, L.P., 26
Lipska, B.K., 177, 248
Lipton, F., 228
Livingston, M., 178
Llama, R., 227
Lo, T., 152,165
Lo, W.H., 152,165
Lodge, D., 250
Loebel, A.D., 44,53,68, 72,97, 119,152,
165,177,179,225,248
Loeffler, W., 67, 96, 97, 98, 99, 119,
120, 141,165
Lohr, J.B. 250
London, E.D., 250
Lonnqvist, J., 66
Lord, A., 65
Lougee, L., 249
Lublin, H., 178
Lukens, E.P., 226, 229
MacDonald, A., 122,178, 248
MacDonald, D.I., 133
MacDonald, E.M., 227, 250
Machon, R.A., 43, 248
Mackie, M., 179
279
MacMillan, J.F., 44, 97,119,133,165,
226
Madison, D.V., 250
Magliano, L., 134
Mahadik, J.S., 250,
Mahadik, S.P., 249, 250, 251
Mahtani, M.M., 249
Maier, W.,66
Mailman, R.B., 251
Malas, K.L., 195
Malhotra, A.K., 250, 251
Malkoff Schwartz, S., 228
Malmberg, A., 28, 248
Mann, S.A., 27
Mannisto, P., 195
Manoach, D., 251
March, J.S., 249
Marchbanks, R.M., 249
Marcus, J., 44,98
Mardal, S., 151
Marder, S.R., 99,127,178-180,187,
194
Marengo, J.T., 99
Marks, I.M.,127, 134
Marmot, M., 26, 67, 98
Marshall, EJ., 248
Marshall, V., 230
280
Martin, D., 251
Masuzawa, Y., 251
Mathis, C., 250
Matsubara, S., 194
Maurer,K., 53, 66,67, 71,96,97,98,99,
119,120,141,165
May,P.R.A., 185,194,248
Mayerhoff, D.I., 44, 68,97, 100,
119,177.180,248
Maylath, E., 180
McCarley, R.W., 248, 251
McCready, R., 178, 179,250
McDermott,B.E., 190,194
McElhinny, L.G., 250
McEvoy, J.P., 180, 186,194
McFarlane, C.A., 97, 120-122,154,229
McFarlane, W., 166,197,225,226,230
McGill, c., 230 McGlashan, T.H., 21, 52,57, 58, 59, 61,67,68,95,100,119,135, 136, 141,151,153,164,165,166,225
McGorry, P.D., 21, 26, 53-58, 66, 68, 69, 72,74,97, 98,101, 119-122, 133,135,142, 153, 158,166,177,178, 206,213,216,224,229,230
McGrath, l.1.,121
McGuffin, P., 248
McGuire,M., 67
McGuire, P.K., 121
McHugh, P.R, 133
McIntyre, I.M., 180
McKenna, K., 248
McLees, S., 122
McNamara, J.O., 249, 251,252
McNeil, T.F., 43,121
McQueen, L.E., 120
McWilliams, L., 251
Mears, A., 120
Medley, I., 66
Mednick, B., 44
Mednick, S.A., 21,26,29,37,42,43,44,
48,66,68,97,121,154,158,165,166,
248
Medus, c., 66
Meehl, P.E., 43
Meeks, S., 228
Meibach, R.C., 194
Meier, T., 69
Meissner, S., 67, 98,120
Melan, c., 250
Melle, 1.,151
Melson, A.K., 251
Meltzer,H.Y., 188,194
Melville, 126
Menzies, C., 179
Mercier, P., 178
Mestrovic, B., 250
Meurice, E.E., 51,68
Mihalopoulos, c., 26, 97, 119, 133, 166
Miklowitz,DJ., 127,134,227,229
Miksa, M., 251
Miller, A., 178
Miller, D., 247
Miller, I.W., 230
Miller, T.J., 135
Mingyuan, Z., 229
Mintz, J., 178
Mirotznik, J., 226
Mirsky, A.F., 44, 98
Missar, C.D., 250
Mittleman, B., 249
Miyakawa, T., 250
Mjorndal, T., 178
Mody, 1.,252
Moeller, H.J. 188, 194
Moghaddam, B., 251
Mohr,P., 182, 191,194
Moises, H.W., 249
Moldin, S.0.,35, 44, 249
Moller, P., 136, 142
Mompo, J., 251
Monteiro, H.P., 250
Mordel, c., 251
Moring, J., 69
Morita, H., 27
Morris, L., 100
Moscarelli, M., 151,165,225
Mossman, D., 27
Motlova, L., 194
Mrazek, P.J., 28,120
Mukhe~ee,S.,178,250,251
Mueller, H., 194
Mueser, K.T., 229
Mulier, H.J., 100
281
Muller, N., 100,249
Muller-Thomsen, T.S.O., 119
Munk-Jorgensen, P., 43,99,120,133,
178
Mumo, J.C., 177
Murata, M., 251
Murrie, V., 121
Murray, G., 248
Murray, R.M., 26,67,98,119, 121,
177,248
Murrell, S.A., 228
Muthen, B., 10, 27
Muthen, L., 27
Myers, J.K., 132
Nagler, S., 44, 98
Naarala, M., 69
Naatanen, R., 67
Nabeshima, T., 251
Nadler, J.V., 251, 252
Nagamoto, H., 250
Nair, T.R., 249
Nakajima, T., 165
Nakashima, Y., 179
Nancarrow, D.J., 249
Nara, Y., 251
Nasrallah, H.A., 69
Nathan, M. 44
Nawroz, S., 177
Negrete, S., 180
Nelson, J., 248
Neri, L., 225
282
Newcomer, I.W., 250, 251
Newton, M.R., 249
Nichols, D.E., 251
Nicolson, R., 119,249
Niemenen, P., 26
Nienhuis, F.I., 248
Niwa, S-I., 52, 68
Nordstrom, A.L., 179, 193
Noring, U., 178
Nowak, H., 69
Nowotny, B., 97, 99, 100, 119
Noy, S.,249
Nuechterlein, K.H., 228
Numano, F., 251
Nyberg, S., 179
Oakley-Browne, M., 133
O'Callaghan, E., 248, 251
O'Dell, T.J., 250
O'Donnell, D.W., 100
O'Hara, P., 178
O'Hare, A., 67
Ohman, A., 228
Oja, G., 179
Olarte, S., 178
Olin, S.S., 37,44, 48,68,97,154,
158,166
Olin, S.C., 121
Olincy, A., 250
Oliviera, I.A., 250
Olney, I.W., 250, 251
Opjordsmoen, S., 151, 152,165,166,
225
Opler, L.A., 142, 166
Oren, D.A., 251
Orza, M.J., 180
Ostrem, J.L., 177
Overall, J.E., 121,138, 141
Paans, A.M., 179
Pallanti, S., 228
Pallardo, F.V., 251
Palmer, B., 178
Pampallona, S., 180
Pantelis, c., 66,121
Pamas, J., 43, 44,48,66,68,97
Pashdag, I., 178
Paskevich, P.A., 180
Patel, M., 249, 250
Patten, S., 99
Paterson, J.R., 250
Pattison, E., 227
Pato, c., 178
Patton, G.c., 120-122, 178
Patton, S.G., 97
Pauli, S., 179
Paus, T., 119, 249
Paykel, E.S., 44
pazzagli, A., 228
Peacock, L., 178
Pearson, 88
Pederson, J., 229
Pedhazur, E.J., 43
Pelucio, M., 178
Penn, D.L., 229
Penninx, B.W., 227
Perez-Velazquez, J.L., 251
Perkins, D., 231
Perlick, D., 227
Perlmutter, S., 249
Pervaiz, S., 251
Peterson, G.A., 179
Peuskens,J., 187,193,194
Phelan, J., 178, 202,227
Phillips, L.J., 97, 101,121,122,178
Piantadosi, CA., 250
Pickar, D., 250, 251
Pietri, S., 250
Pinals, D.A., 250, 251
Pincus, H.A., 120,133
Pi-Sunyer, F.X., 178
Pluck, J., 100
Pogue-Geile, M.F., 99
Polatin, P.H., 48, 67
Poletti, A., 133
Popli, A.P., 179
Post, R.M., 225,226,249
Potvin, J.H., 178
Poustka, F., 100
Poutanen, V-P., 66
Praesthold, J., 44
Prehn, J.H., 251
Preskom, S.H., 193
Price, M.T., 251
Prien, R.F.,127,134
Prohovnik, I., 249
Purdon, S.E., 178
Putnam, K.M., 193
Quercioli, L., 228
Rabe-Hesketh, S., 26, 248
Rabin, B.S., 249
Rabiner, C.J.,152, 165,176,225
Rainer, J.D., 65
Rakkar, A., 97, 120
Rakkolainen, V., 67, 100
Rajapakse, J.C, 248
Ram, R., 178
Ramchand, CN., 250
Rames, L.J., 179
Randolph, E.T., 211, 229
Rantakallio, P., 26,98
Rapaport, J., 67, 119, 248, 249
Raphael, B., 68, 119
Reddy, R.D., 249, 250
Reerenhovi, L., 193
Reiger, D.A., 133
Reisby, N., 43
Reiss, D.J., 133,230
Reiter, G., 100
Rekola, J., 65
Reivich, K.J., 120
Remington, G., 167, 178-180, 194
Reveley, A.M., 248
Reynolds, I., 134
Ribchester, T.R., 228
283
284
Rich, C., 178
Richelson, E., 251
Rigby, M., 251
Riecher-Rossler,A., 67, 97, 98, 99,120
Riecher, A., 98
Riedel, M., 249
Rifkin,A., 186,194
Riordan, H., 100
Rishovd-Rund, B., 165
Ritter, W., 67
Roberts, S., 44, 120
Robins, E., 165
Robinson, D.G.,177,180, 248
Rock, D., 44, 120
Rockwell, E., 178
Rogers, S.W., 249
Rodgers, B., 26, 27, 67, 98
Rosberg, T., 68
Rose, Geoffrey, 22,28
Rosen, A.M., 178
Ross, J.M., 27
Ross-Chouinard, A., 178
Rossell, S., 121
Rosser, R.M., 133
Rotrosen, J., 179
Rubin, E., 250
Rubinstein, J., 178
Ruohonen, J., 67
Ruotsalainen, Y., 67
Rupp, A., 225
Rush, AJ., 133
Russell, A., 119, 177
Rutter, M., 27
Saarento, 0., 69
Sacker, A., 26, 28
Sackett, D.L., 27
Sadock, B., 194
Sagara, Y., 249
Saitoh, 0., 68
Sakuma, M., 248
Salokangas, R.K.R., 21,48, 52, 67, 69,
99,100,138
Salonen, 0., 66
Sanger, T.M., 178,195
Sarentakos, S., 134
Sartorius, N., 27, 98, 133
Sastre J., 251
Sauer, H., 180
Saugstad, L.F., 177
Saurer,H., 52, 68
Schaich, K.M., 249
Scheffer, R.E., 249, 250
Scherrer,S., 180
Schmeck, K., 100
Schmelkin, L.P., 43
Schmiedtke, A., 67, 98, 120
Schoenfeld, D.A., 251
Schoenfeld, P., 228
Schooler, N.R., 165, 180, 211,229,248
Schotte, A., 194
Schroder, J., 180
Schubart, c., 99
Schulsinger, F., 43, 44, 68, 97
Schulsinger, H., 43, 44, 68, 97
Schultze-Lutter, F., 68, 98, 141
Schuman, E.M., 250
Schuttler, R, 67,165
Schwartz, J.E., 99
Schwarz, MJ., 249
Scully, PJ., 177
Sedvall, G., 179
Seeman,M., 180
Seibyl, J.P., 250
Seidman, LJ., 26
Seitamaa. M., 69
Selemon, L.D., 248
Seligman, M.E., 120
Selke, G., 251
Selten, J.P., 248
Sesma, M.A., 251
Servan-Scbreiber, D., 67
Severe, J.B., 229
Sham, P.c., 119, 248
Shammi, C.M., 180
Shanahan, W.J., 122
Shapiro, RM., 177
Shapleske, J., 121
Sharma, R.P., 193
Shaw, B.F., 133
Sheitman, B., 177, 180, 248, 249
Shelton, P.S., 178
Shenton, M.E., 248
Shepherd, M., 99,133
Shields, J., 43
Shimizu, Y., 251
Shiue, C.Y., 179
Shuttler, R., 248
Simhandl, c., 178
Shona, M.F., 166
Shouldon, I., 249
Siever, L., 193
Sikich, L., 251
Silipo, G., 251
Silvestri, S., 180
Simon,H., 183,194
Simonsen, E., 151
Simpson, H.R, 27
Singer, J., 194
Singer, M., 227
Singh,B., 56,66, 68, 119, 121
Singh,S., 66
Sipila, P., 26, 98
Siris, S.G., 99
Sirocco, K., 250
Slooff, CJ., 179, 248
Smeeton, N., 99
Smith, A., 248
Smith, D., 251
Smith, G.N., 97
Smith, T.E., 194
Smythies, J.R., 250
Snyder, S.H., 250
Sohal, RS., 249
Sohn, S., 251
285
286
Sokolovsky, J., 227
Solgaard, T.,178
Solin,O.,67
Solomon, P., 227, 228
Sorri, A., 69
Squires-Wheeler, E., 97,120
Spellberg, BJ., 179
Spellman, M., 67
Spigset, 0., 179
Spitzer, R.L., 165
Spring, B., 226
Stamler, J.S., 250
Standerskold-Nordenstam, C-G., 66
Stastny, P., 230
Stefovska, Y., 251
Stein, L.I.,127, 133
Steinberg,H., 203,228
Steingard, S., 180, 194
Steinglass,P., 217, 230
Steinhauer, S.R., 69, 226
Steinmeyer, E.M., 68, 98,141
Steinwachs, D.M., 165, 166
Stengard, E., 99, 100
Stevens, K., 250
Stevens, J.R., 249
Stewen, A., 65
Stoffel, M., 249
Stone, C.K., 180
Strachan,A., 201, 226
Strauss, 160
Strong, D., 177
Stutzmann, J.M., 250
Suboticanec,K.,250
Sullivan, H.S., 102, 103,119,165
Sumiyoshi, S., 250
Suppes, T., 225
Susser, E.S., 248
Sutter, FJ., 194
Suzuki, M., 27
Suzuki, T., 250
Swedo, S.E., 249
Sweeney, J.A., 152,165, 177,225
Sylvalahti, E., 67
Szymanski, S.R., 44,68,97,119, 177,
248
Tagami, M., 251
Tallerico, T., 180
Talovic, S.A., 44
Takala, K., 65
Takei, N., 248
Takeuchi, D.T., 228
Tamminga, C.A., 250, 251
Tamura, R.N., 178
Tanabe, E., 251
Tanaka, T., 251
Tanskanen, A., 26, 248
Tarazi, F.I., 180
Tarrier, N.,127, 133, 229
Tatetsu, S., 250
Taylor, c., 249
Teasdale, T.W., 43, 44, 68
Teicher, M.H., 179
Tenkova, T.!., 251
Tenner, A., 249
Terry, W.M., 249
Test, M.A.,127, 133
Tew, W.,248
Thau, K., 178,182,194
Thiele, D.A., 248
Thompson, M.A., 252
Tien,A.Y., 182,194
Tienari, P., 44, 48,50, 69
Tierney, P., 121
Tiffany, S.M., 250
Tischler, G.L., 132
Tizard, J., 27
Todd, P.,99
Tohen, M., 178
Tokumaru, S., 251
Tollefson, G.D., 178,188,195
Tolsdorf, C., 228
Tomonari, H., 250
Tomov, T., 98
Toone, B.K., 119
Tran, P.V., 178
Traynelis, S.F., 250
Tsai, G., 251
Tsuang, M.T., 26
Tucker, D., 225
Tugwell, P., 27
Tuma, A.H., 177,194,248
Tuomisto,l., 191,195
Tuovinen, M., 65
Turetsky, B.I., 248
Turski, L., 251
Tyrka, A.R., 42
Ulrich, R., 229
Umbricht, D., 178
Uppfeldt, G., 179
Vaalburg, W., 179
Vaglum, P., 120,151
Vaituzis, A.C., 248
Valanne, L., 66
Van Berckel, B., 251
Van der Graaf, Y., 248
an der Heiden, W., 96-100, 119,120
Vander Heiden, W.,67
Van der Linden, J.A., 251
Van Dusen, K., 44
van Duursen, R., 248
Vanelle, J.M., 187,195
van Erp, T.G.M., 66
Vangeneugden A., 193
287
van Kammen, D.P., 99,187,195,250
Van as, J., 2,26,121,228,248
Van Praag, H., 193
van Ree, J.M., 251
Varia, V., 178
Vaughn, C., 133, 226
Vazquez-Barquero, J.L., 100
Velakoulis, D., 66,121
Venables, P.H., 44, 52, 69
Venturi, P., 248
Verma, A., 251
288
Verma, S.K., 228
Vestergaard, A., 44
Vilkman, H., 67
Vina, J., 251
Vina, J.R., 251
Vito, P., 249
Volavka,1., 186,195
Volz, H.P., 69
Virtanen, J., 67
Vital-Herne, J., 177
Vuorio, K., 67
Waddington, J.L., 177
Wadsworth, M.E.J., 25,26,27
Wagener, D.K., 227
Wagman, A.M., 193
Wahlberg, K-E.,69
Waldo, M., 250
Walker, E., 42,50,65,69
Wallace, C.J., 127,133
Wallace, D.C., 249
Walsleben, J., 177
Walsh, D., 67
Wang, G., 251
Waters, N., 251
Watt, D., 99
Watt, N.F., 44
Wegner, J.T., 165, 176,225
Weiden, PJ., 194
Weinberger, D.R., 66, 68, 69, 100, 177,
248
Weingartner, H., 250
Weissman, M.M., 132
Wells, J.E., 133
West, A., 44
Westenberg, H.G.M., 251
Westermeyer, J.F., 99
Weyerer, S., 133
Whatley, S.A., 249
Whisenand, T., 249
Whitmore, K., 27
Whitney, K.D., 249
Wible, C.G., 248
Wiegman, T., 179
Wieneke,A., 68
Wiersma, D., 248
Wiesel, F.A., 179, 193
Wieselgren, I.M., 228
Wightman, K.A., 251
Wilcox, G.L., 250
Wiles, D.H., 179,250
Wilkins, S., 119
Williams, S.c., 121
Willson, N., 249
Wilson, A., 179, 180
Wing, J.K., 27, 98, 126,133,178,226
Wirshing, D.A., 178, 179
Wirshing, W.c., 178,179
Woerner, M., 134, 177, 180,248,249
Wolf, A.P., 179, 195
Wolkin, A., 179,191,195
Wolkowitz, O.M., 193
Wolozin, B., 249
Wolpert, E.M., 98
Woodroffe, R.W., 134
Woodruff, P.W., 121
Wood, G.K., 248
Woods, B.T., 121, 177
Woods, S.W., 135
World Health Organization, 98, 133
Wozniak, D.F., 251
Wright, I.C., 121
Wyatt, R.J., 119,133,152,153,165,
177,225,248
Wynne, L.c., 69
Yale, c., 248
Yamatani, H., 228
Yamori, Y., 251
Yan, M.,66
Yang, L., 249
Yang, P., 251
Yang, Z.W., 249
Yao, J .K., 249, 250
Yasouka, F., 250
Yaziki, K.M., 179
Yeh, G-C., 251
Yuen,H.P.,121
Yung,A.R., 53-56, 66, 69, 72, 99, 101,
120-122,136-138,142,177,178,230
Zamkoff, J., 249
Zhang-Wong, J., 179
Ziebell, S., 177
Zijdenbos, A., 119,249
Zipursky, B., 167,178-180
Zorumski, C.F., 250
Zubin, J., 69, 99, 226
Zukin, S.R., 250
289